Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Teleflex Continues Restructuring By Selling Hudson Respiratory Business To Medline

Executive Summary

Medline will pay $286m in cash for Teleflex's oxygen and aerosol therapy, active humidification, and non-invasive ventilation devices as well as incentive spirometers. Those businesses yielded $139m in 2020 revenues, but do not fit into Teleflex's plan for the future.

You may also be interested in...



Teleflex Adds Hemostatic Products With $525M Acquisition Of Z-Medica

Z-Medica’s wound care products, led by its QuikClot Control+ hemostatic dressing, complement Teleflex’s existing line of products marketed to first responders and the military.

Zimmer Biomet Creates Non-Profit To Address Health Disparities

The orthopedics company has created an independent non-profit structure for Movement is Life, Inc., the philanthropic, multi-disciplinary coalition that it founded in 2010. The coalition’s mission is to improve musculoskeletal health for women, underserved racial and ethnic groups, and people living in rural communities.

Boston Scientific Plans New Facility In Georgia

The company will invest $62.5m for a new manufacturing and supply chain facility in Johns Creek, GA – about 30 miles northeast of Atlanta in Fulton County, according to Georgia Governor Brian Kemp.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT143945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel